Nalmefene hydrochloride 1mg/mL (equivalent to 1mg nalmefene base); per vial; soln for IV, IM, or SC inj. IV route preferable: see full labeling. Reversal of opioid effects: see full labeling ...

Each single-dose Zurnai autoinjector delivers a dose of 1.5mg nalmefene (base) in 0.5mL. The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for ...

1 Imbrium Therapeutics L.P. (“Imbrium”), a subsidiary of Purdue, sponsored this study. Nalmefene hydrochloride injection is an opioid antagonist indicated for the complete or partial reversal ...

The drug is called Opvee and was approved by the FDA in May of 2023 and is the first Nalmefene nasal spray to be approved. It is another step further in helping fight overdoses both from addiction ...

Astute Analytica has released a comprehensive report titled North America & Europe Nalmefene Hydrochloride Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.